By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.




Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden


Please click here for Teva Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA


Company News
Teva (TEVA) Rallies Despite FDA Warning Letter 10/21/2016 6:44:53 AM
Teva (TEVA) Announces FDA Acceptance Of Resubmitted New Drug Application For SD-809 For Treatment Of Chorea Associated With Huntington Disease 10/20/2016 1:14:36 PM
Regeneron (REGN) And Teva (TEVA) Provide Update On Fasinumab Clinical Development Programs 10/17/2016 1:35:33 PM
Teva (TEVA) Receives Positive Opinion From EMA'S Committee For Medicinal Products For Human Use (CHMP) To Extend Indication Of Trisenox For First Line Treatment Of Low- To Intermediate Risk Acute Promyelocytic Leukemia (APL) 10/17/2016 12:54:00 PM
FDA Slaps Hold on Regeneron (REGN), Teva (TEVA)'s Pain Drug Fasinumab 10/17/2016 5:27:35 AM
Teva (TEVA) Announces Launch of Generic Beyaz in the United States 10/12/2016 11:14:57 AM
Week In Review: Teva (TEVA) Pays $160 Million For US/Canada Rights To Celltrion (068270.KQ) Biosimilars 10/10/2016 9:19:29 AM
Teva (TEVA) Pays $160 Million to Celltrion (068270.KQ) in Biosimilar Hook-Up 10/6/2016 7:03:59 AM
Teva (TEVA) Divests Allergan (AGN)'s Generics Biz in UK, Ireland for $769 Million 10/5/2016 9:50:13 AM
Teva (TEVA) Completes Acquisition Of Anda 10/3/2016 10:45:49 AM